Prostate cancer detection: A view of the future

European Urology

Volumn 59, Issue 2, 2011, Pages 191-193

  Thompson Jr , Ian M ^a   Leach, Robin J ^a   Ankerst, Donna P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 78650700429     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.11.019     Document Type: Editorial

References (8)

1. A. Jemal, R. Siegel, J. Xu, E. Ward, and Cancer Statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. NCCN Clinical Practice Guidelines in Oncology. Prostate cancer early detection. V.2.2010. National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/physician-gls/PDF/prostate-detection.pdf.
3. Y.H. Shao, P.C. Albertsen, and C.B. Roberts Risk profiles and treatment patterns among men diagnosed as having prostate cancer and prostate-specific antigen level below 4.0 ng/mL Arch Int Med 170 2010 1256 1261
4. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncl 28 2010 1117 1123
5. L. Klotz, L. Zhang, A. Lam, R. Nam, A. Mamedov, and A. Loblaw Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
6. P.J. van Leeuwen, K. Kölble, H. Huland, T. Hambrock, J. Barentsz, and F.H. Schröder Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies Eur Urol 59 2011 183 190
7. I.M. Thompson, C. Chi, and D.P. Ankerst Effect of finasteride on the sensitivity of PSA for detecting prostate cancer J Natl Cancer Inst 98 2006 1128 1133
8. I.M. Thompson, D.P. Ankerst, and C. Chi Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower JAMA 294 2005 66 70 (Pubitemid 41002840)